Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia - Verification of leukemic state by flow-sorting and molecular/cytogenetic methods

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Increments in DNA-thioguanine level during thiopurine enhanced maintenance therapy of acute lymphoblastic leukemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Targeting the tumor microenvironment in chronic lymphocytic leukemia

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer
Reduction in minimal residual disease, measured by real-time quantitative PCR or flow cytometry, predicts prognosis in childhood B-cell precursor acute lymphoblastic leukemia. We explored whether cells reported as minimal residual disease by flow cytometry represent the malignant clone harboring clone-specific genomic markers (53 follow-up bone marrow samples from 28 children with B-cell precursor acute lymphoblastic leukemia). Cell populations (presumed leukemic and non-leukemic) were flow-sorted during standard flow cytometry-based minimal residual disease monitoring and explored by PCR and/or fluorescence in situ hybridization. We found good concordance between flow cytometry and genomic analyses in the individual flow-sorted leukemic (93% true positive) and normal (93% true negative) cell populations. Four cases with discrepant results had plausible explanations (e.g. partly informative immunophenotype and antigen modulation) that highlight important methodological pitfalls. These findings demonstrate that with sufficient experience, flow cytometry is reliable for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia, although rare cases require supplementary PCR-based monitoring.
Udgave nummer1
Sider (fra-til)137-141
StatusUdgivet - 2012

ID: 33119495